Template:DM outpatient managment: Difference between revisions
(Created page with "*1st line Metformin 500mg BID --> 1000mg BID, do not give in people with abnormal LFT's, CHF Stage 3/4 and ARI, CKD *2nd Agent Glipizide start 2.5mg BID -->5mg BID, ne...") |
No edit summary |
||
| Line 1: | Line 1: | ||
===[[Diabetes]] Outpatient Management=== | |||
*1st line [[Metformin]] 500mg BID --> 1000mg BID, do not give in people with abnormal LFT's, CHF Stage 3/4 and ARI, CKD | *1st line [[Metformin]] 500mg BID --> 1000mg BID, do not give in people with abnormal LFT's, CHF Stage 3/4 and ARI, CKD | ||
*2nd Agent [[Glipizide]] start 2.5mg BID -->5mg BID, need to monitor for hypoglycemia | *2nd Agent [[Glipizide]] start 2.5mg BID -->5mg BID, need to monitor for hypoglycemia | ||
Revision as of 11:46, 18 January 2017
Diabetes Outpatient Management
- 1st line Metformin 500mg BID --> 1000mg BID, do not give in people with abnormal LFT's, CHF Stage 3/4 and ARI, CKD
- 2nd Agent Glipizide start 2.5mg BID -->5mg BID, need to monitor for hypoglycemia
- 3rd Agent Pioglitazone
- After 3 agents need to start insulin if not controlled
- NPH BID or Lantus Qday (0.5mg/kg) and titrate to Fasting Blood Sugar